This site has been designed to assist the media in easily accessing contact and background information about Roche Diagnostics in the United States. As the world leader in in-vitro diagnostics, Roche has an extensive product portfolio, which spans predisposition screening, targeted monitoring, prevention, diagnosis, therapy and therapy monitoring systems, as well as its pipeline of new technology-based products (genetics, genomics and proteomics). Our goal is to partner with news reporters and provide relevant information that is of interest to various targeted audiences.

News Media Contacts:

These contacts are for media requests only.

For Investor Relations information, visit our IR website.